memantine has been researched along with Anochlesia in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Moreover, its use is less toxic and safer." | 1.42 | Comparison of Pharmacological Potency and Safety of Glutamate Blocker IEM-1913 and Memantine. ( Gmiro, VE; Serdyuk, SE; Veselkina, OS, 2015) |
| "NMDA-induced convulsions were effectively prevented by both mono- and dications, while only dications were effective against kainate convulsions." | 1.32 | The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals. ( Gmiro, VE; Gorbunova, LV; Lukomskaya, NY; Rukoyatkina, NI, 2003) |
| "However, in the haloperidol-induced catalepsy test the efficacy of amantadine was higher than memantine, while the opposite was true for rotation and reserpine-induced sedation indicating pharmacodynamic differences between both agents." | 1.29 | Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine. ( Danysz, W; Dill, D; Gossel, M; Quack, G; Zajaczkowski, W, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gmiro, VE | 2 |
| Serdyuk, SE | 1 |
| Veselkina, OS | 1 |
| Rukoyatkina, NI | 1 |
| Gorbunova, LV | 1 |
| Lukomskaya, NY | 1 |
| Maj, J | 2 |
| Wesemann, W | 1 |
| Sontag, KH | 1 |
| Danysz, W | 2 |
| Gossel, M | 1 |
| Zajaczkowski, W | 1 |
| Dill, D | 1 |
| Quack, G | 1 |
| Hesselink, MB | 1 |
| Smolders, H | 1 |
| De Boer, AG | 1 |
| Breimer, DD | 1 |
1 review available for memantine and Anochlesia
| Article | Year |
|---|---|
[Pharmacodynamics and pharmacokinetics of memantine].
Topics: Amantadine; Animals; Antidepressive Agents; Body Temperature; Catalepsy; Dopamine; Dyskinesia, Drug- | 1983 |
5 other studies available for memantine and Anochlesia
| Article | Year |
|---|---|
Comparison of Pharmacological Potency and Safety of Glutamate Blocker IEM-1913 and Memantine.
Topics: Analgesics; Animals; Anticonvulsants; Antidepressive Agents; Antiparkinson Agents; Bridged-Ring Comp | 2015 |
The ability of new non-competitive glutamate receptor blockers to weaken motor disorders in animals.
Topics: Animals; Ataxia; Behavior, Animal; Catalepsy; Diamines; Disease Models, Animal; Dizocilpine Maleate; | 2003 |
[Effect of memantine on central neurotransmitter systems. Review of the results].
Topics: Acetylcholine; Amantadine; Animals; Blood Pressure; Catalepsy; Central Nervous System; gamma-Aminobu | 1982 |
Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine.
Topics: Amantadine; Animals; Catalepsy; Dizocilpine Maleate; Locomotion; Male; Memantine; N-Methylaspartate; | 1994 |
Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
Topics: Amantadine; Animals; Ataxia; Avoidance Learning; Behavior, Animal; Catalepsy; Dizocilpine Maleate; D | 1999 |